Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dexcom (DXCM) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Dexcom (DXCM) over the last 12 years, with Q4 2025 value amounting to 0.26%.

  • Dexcom's Return on Invested Capital rose 200.0% to 0.26% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.26%, marking a year-over-year increase of 200.0%. This contributed to the annual value of 0.29% for FY2025, which is 600.0% up from last year.
  • Per Dexcom's latest filing, its Return on Invested Capital stood at 0.26% for Q4 2025, which was up 200.0% from 0.22% recorded in Q3 2025.
  • Over the past 5 years, Dexcom's Return on Invested Capital peaked at 0.36% during Q1 2021, and registered a low of 0.11% during Q2 2022.
  • Moreover, its 5-year median value for Return on Invested Capital was 0.21% (2023), whereas its average is 0.21%.
  • Data for Dexcom's Return on Invested Capital shows a peak YoY increase of 1600bps (in 2021) and a maximum YoY decrease of -2500bps (in 2021) over the last 5 years.
  • Over the past 5 years, Dexcom's Return on Invested Capital (Quarter) stood at 0.11% in 2021, then surged by 52bps to 0.17% in 2022, then rose by 22bps to 0.21% in 2023, then increased by 14bps to 0.24% in 2024, then grew by 7bps to 0.26% in 2025.
  • Its last three reported values are 0.26% in Q4 2025, 0.22% for Q3 2025, and 0.21% during Q2 2025.